Dose-response relationship seen with risk heightened with longer duration exposure
ACC: Semaglutide Beneficial in Obesity-Related Heart Failure, Type 2 Diabetes
Larger reductions seen in heart failure-related symptoms and physical limitations for patients with HFpEF, type 2 diabetes
ACC: Ventura Shunt Does Not Improve Primary End Point in Heart Failure
Improvements noted across all outcomes assessed in patients with heart failure with reduced ejection fraction
Etidronate Beneficial for Arterial Calcification Due to CD73 Deficiency
Etidronate seems to slow progression of further vascular calcification